Showing results (321-330 of 346) with videos related to
Sort By:
Pageof 35
Cancer Chemotherapy and Pharmacology|January 1, 1978
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histologyT A Lister, M H Cullen, R B Brearley, et al.British Journal of Cancer|July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fosså, S P Stenning, A Gerl, et al.Physiological Genomics|February 13, 2001
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2N S Delany, M Hurle, P Facer, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2016
Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T CellsBruno Laugel, Angharad Lloyd, Erin W Meermeier, et al.British Medical Journal|December 4, 1976
Intensive investigation in management of Hodgkin's diseaseS B Sutcliffe, P F Wrigley, J F Smyth, et al.British Journal of Cancer|November 1, 1973
Immunotherapy for acute myelogenous leukaemiaR L Powles, D Crowther, C J Bateman, et al.British Medical Journal|January 28, 1978
Combination chemotherapy for acute lymphoblastic leukaemia in adultsT A Lister, J M Whitehouse, M E Beard, et al.Lancet (London, England)|April 16, 1983
Controlled trial of adjuvant chemotherapy with melphalan for breast cancerR D Rubens, J L Hayward, R K Knight, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupA Le Cesne, I Judson, D Crowther, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study GroupM Loeffler, O Brosteanu, D Hasenclever, et al.Pageof 35